THE EFFECTIVENESS OF PSYCHIATRIC THERAPY AGAINST MALAYSIAN CANCER PATIENTS WITH DEPRESSIVE DISORDERS: A SYSTEMATIC REVIEW
Abstract
The aim of this study is to compare depression in terms of treatment between psychotherapy and medical approach or to combine these approaches among cancer patients in Malaysia with respect to the cancer categories. It also studies the major prevalence of depressive disorder in the group together with the specialized clinical connection to the health outcomes. The annual incidence of cancer cases in Malaysia is 30,000 at late stage of the disease. We found 17 eligible researches out of 142 articles which most were under designed of cross-sectional or prospective study, and contained 2,523 cancer patients. This study was conducted on systematic electronic review using the databases such as PubMed, Scopus, ScienceDirect, Google Scholar, Wiley Online Library were carried out from the period of time between 2006 and 2015, for the data collection, the study goes through the Malaysian articles in English language, in which some of the considered factors were general management principles, cancer level among the depressed patients, the selection of the psychological therapies and the use of antidepressant medication. However, the evidences are still not enough to present an effective diagnostic method for the depressive disorders in cancer patients, and to find a successful antidepressant drug and/or an appropriate psychotherapy in this group of patients. Hence, many different approaches could be presented for psychotherapy. In conclusion, we found increased hazard rates for the cancer death among psychiatric patients compared to the control group without a registered mental illness.
Full Text:
PDFReferences
Chan, C. M. H., Wan Ahmad, W. A., Yusof, M., Ho, G.F. & Krupat, E. (2015). Prevalence and characteristics associated with default of treatment and follow-up in patients with cancer. Eur. J. Cancer Care, 24, 938-944.
Cheung, F. M., Cheung, S. F., Wada, S. & Zhang, J. X. (2003). Indigenous measures of personality assessment in Asian countries: A review. Psychological Assessment, 15, 280-289. doi:10.1037/1040-3590.15.3.280
Colleoni, M., Mandala, M., Peruzzotti G., Robertson, C., Bredart, A. &
Goldthirsch, A. (2000). Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet, 356, 1326-1327.
Cullivan, R., Crown, J. & Walsh, N. (1998). The use of psychotropic medication in patients referred to a psycho-oncology service. Psycho-oncology, 7(4), 301-306.
Ell, K., Quon, B., Quin, D., Dwight-Johnson, M., Wells, A., Lee, P. J. & Xie, B. (2007). Improving treatment of depression among low-income patients with cancer: the design of the ADAPt-C study. Gen. Hosp. Psychiatry, 29(3), 223-231.
Gan, G. G., Leong, Y.C., Bee, P. C., Chin, E. & Teh, A. K. H. (2015). Complementary and alternative medicine use in patients with hematological cancers in Malaysia. Support Care Cancer, 23, 2399-2406.
Grassi, L., Nanni, M. G., Uchitomi, Y. & Riba, M. (2010) Pharmacotherapy of Depression in People with Cancer, in Depression and Cancer (eds D. W. Kissane, M. Maj and N. Sartorius), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470972533.ch7
Haaga, D. A., Dyck, M. J. & Ernst, D. (1991). Empirical status of cognitive theory of depression. Psychological Bulletin, 110(2), 215-236.
Hatta, J. M. M., Doss, J. G. & Rogers, S. N. (2014). The feasibility of using patients concerns inventory (PCI) in managing Malaysian oral cancer patients. Int. J. Oral Maxillofacial Surg., 43, 147-155.
Hassan, M. R., Shah, S. A., Ghazi, H. F., Mujar, N. M. M., Samsuri, M. F. & Baharom, N. (2015). Anxiety and depression among breast cancer patients in an urban setting in Malaysia. Asian Pac. J. Cancer Prev., 16(9), 4031-4035.
Jesse, R. F., Anne, M. T. R., Wayne, J. K., Deborah, C., Mary, P., Bonnie, A. M. & Julie, G. (2008). Major depression after breast cancer: a review of epidemiology and treatment. Gen. Hosp. Psychiatry, 30, 112-126.
Leong Abdullah, M. F. I., Nik Jaafar, N. R., Zakaria, H., Rajandram, R. K., Mahadevan, R., Yunus, M. R. M. & Azhar Shah, S. (2015). Posttraumatic growth, depression and anxiety in head and neck cancer patients: examining their patterns and correlations in a prospective study. Psycho-Oncology, 24, 894-900.
Lim, G. C. (2002). Overview of cancer in Malaysia. Jpn. J. Clin. Oncol., 32 Suppl: S37-42.
Lloyd-Williams, M. Friedman, T and Rudd, N. An analysis of the validity of the hospital anxiety and depression scale as a screening tool in patients with advanced metastatic cancer. J. Pain Symptom Manage., 22(6), 990-996.
Schroevers, M.J. & Teo, I. (2008). The report of posttraumatic growth in Malaysian cancer patients: relationships with psychological distress and coping strategies. Psycho-Oncology, 17, 1239-1246.
Massie, M. J. & Popkin, M. K. (1998). Depressive disorders. In: Holland, J.C. (Eds). Psycho-oncology. New York: Oxford University Press, 518-519.
Mei Hsien, C. H., Wan Azman, W.A., Yusof, M. M., Ho, G. F. & Krupat, E. (2012). Discrepancy in patient-rated and oncologist-rated performance status on depression and anxiety in cancer: a prospective study protocol. BMJ Open, 2: e001799. Doi: 10.1136/bmjopen-2012-001799
Moher, D., Liberati, A., Tetziaff, J., Altman, D. G. & PRISMA Group. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med., 6(7), e1000097. doi: 10.1371/journal.pmed.1000097.
Moorey, S., Cort, E., Kapari, M., Monroe, B., Hansford, P., Mannix, K., Henderson, M., Fisher, L. & Hotopf, M. (2009). A cluster randomized controlled trial of cognitive behaviour therapy for common mental disorders in patients with advanced cancer. Psychological Medicine, 39(5): 713–723.
Mukhtar, F. & Tian, P. S. O. (2011). A review on assessment and treatment for depression in Malaysia. Depression Research and Treatment, 8 pages, doi:10.1155/2011/123642
Niang, K. N. J., Nor Azillah, A. A., Nooriny, I., Tan, C. H., Yeow, Y. Y. & Hamidin, A. (2010). Anxiety and depressive symptoms and coping strategies in nasopharyngeal carcinoma patients in Hospital Kuala Lumpur. Malaysian Journal of Medicine and Health Sciences, 6(1), 71-81.
Ng, C. G., Boks, M. P., Zinal, N. Z. & de Wit, N. J. (2011). The prevalence and pharmacotherapy of depression in cancer patients. J. Affect. Disord., 131(1-3), 1-7. doi: 10.1016/jad.2010.07.034.
Ng, C. G., Mohamed, S., Tai, Y. W., Haris, A., Zainal, N. Z. & Sulaiman, A. H. (2014a). Comparison of psychotropic prescriptions between oncology and cardiology inpatients: Results from a pharmacy database in a teaching hospital in Malaysia. Asian Pac. J. Cancer Prev., 15(10), 4261-4264.
Ng, C. G., Boks, M. P., Roes, K. C., Zainal, N. Z., Sulaiman, A. H., Tan, S. B. & de Wit, N. J. (2014b). Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients: a four-week, randomized, double-blinded, placebo-controlled study. Eur. Neuropsychopharmacol., 24(4), 491-498.
Maeda, T. (2008). The effect of psychological intervention on personality change, coping and psychological distress. Asian Pac. J. Cancer Prev., 11, 27-30.
Malaysian Psychiatric Association (2004). Consensus statement on management of depression. Community programme on depression. Retrieved 9th August 2004, from http://www.psychiatry-malaysia.org/html
Massie, M. J. (2004). Prevalence of depression in patients with cancer. J. Natl. Cancer Inst. Monogr., 32, 57-71.
Parkin, D. M., Bray, F., Ferlay, J. & Pisani, P. (2005). Global cancer statistics, 2002. CA Cancer J. Clin., 55(2), 74-108.
Perasamy, U., Sidik, S. M., Rampal, L. & Ismail, S. I. F. (2015). Outcome of chemotherapy counseling by pharmacists on psychological effects and self esteem among oncology patients in a Government Hospital in Malaysia. Med. J. Malaysia, 70(3), 131-141.
Poovaneswaren, S., Lau, F., Teh, J., Idros, I. & Cheah, Y. (2013). Depression in breast and colorectal cancer patients undergoing chemotherapy at Hospital Tuanku Jaafar, Seremban. European Journal of Cancer, 4951: S17.
Raison, C. L. & Miller, A. H. (2003). Depression in cancer: New developments regarding diagnosis and treatment. Biol. Psychiat., 54, 283-294.
Rodin, G., Lioyd, N., Katz, M., Green, E., Mackay, J. A. & Wong, R. K. (2007). Supportive Care Guidelines Group of Cancer Care Ontario Program in Evidence-Based Care The treatment of depression in cancer patients: a systematic review. Support Care Cancer, 15(2), 123-136.
Saniah A.R. and Zainal, N.Z. (2010). Anxiety, depression and coping strategies in breast cancer patients on chemotherapy. Malaysian J. Psychiatry, 19, 16.
Spitzer, R. I., Williams, J. B. W., Gibbon, M. & First M. B. (1990). Structured Clinical Interview for DSM-III-R, Patient Edition/Non-patient Edition, (SCID-P/SCID-NP), Washington, D. C.: American Psychiatric Press, Inc.
Suthahar, A., Gurpreet, K., Ambigga, D., Dhachayani, S., Fuad, I.,
Maniam, T., Osman, C. B. & Ainsah, O. (2008). Psychological distress, quality of life and coping in cancer patients: a prospective study. Med. J. Malaysia, 63(5), 362-368.
Tee, B. C., Phang, C. K., Rasidi, A., Rushdan, M., Alyasand, I. & Hatta, S. (2013). The prevalence and risk factors of major depressive disorders in gynaecological cancer patients. Malaysian Journal of Medicine and Health Sciences, 9(2), 53-61.
Wells, A. A., Palinkas, L. A., Qiu, X. & Ell, K. (2011). Cancer patient’ perspectives on discontinuing depression treatment: the ‘drop out’ phenomenon. Patient Preference and Adherence, 5, 465-470.
Williams, S. & Dale, J. (2006). The effectiveness of treatment for depression/depressive -symptoms in adults with cancer: a systematic review. Br. J. Cancer, 94(3), 372-390.
Zainal, N., Hui, K., Hang, T. & Bustam, A. (2007). Prevalence of distress in cancer patients undergoing chemotherapy. Asia-Pac. J. Clin. Oncol., 3, 219-223.
Refbacks
- There are currently no refbacks.
DISCLAIMER
The editors and publisher of Jurnal Psikologi Malaysia have made every possible effort to verify the accuracy of all information contained in this publication. Any opinions, discussions, views and recommendations expressed in the article are solely those of the authors and are not of Jurnal Psikologi Malaysia, its editors or its publisher. Jurnal Psikologi Malaysia, its editors and its publisher will not be liable for any direct, indirect, consequential, special, exemplary, or other damages arising therefrom.